Photodynamic therapy using porfimer sodium as an alternative to cystectomy in patients with refractory transitional cell carcinoma in situ of the bladder

Journal of Urology

Volumn 160, Issue 1, 1998, Pages 39-44

  Nseyo, Unyime O ^m   Shumaker, Bryan ^m   Klein, Eric A ^m   Sutherland, Karole ^m   Bueschen, Anton ^a   Crawford, E David ^b   Drouin, Guy ^c   Hoodin, Asher ^d   Huben, Robert ^e   Heney, Niall ^f   Jewett, Michael ^g   Koch, Michael ^h   Lamm, Donald ⁱ   Oliver, John ^j   Psihramis, K ^k   Smith, Joseph ^l  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c Montreal Centre   (Canada)

^d JEWISH HOSPITAL   (United States)

^e ROSWELL PARK CANCER INSTITUTE   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

^g UNIVERSITY OF TORONTO   (Canada)

^h VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ WEST VIRGINIA UNIVERSITY   (United States)

^j ROYAL VICTORIA HOSPITAL   (Canada)

^k Danville Urological Clinic   (United States)

^l VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^m NONE

more..

Author keywords

Bladder neoplasms; Carcinoma in situ; Photosensitizing agents; Phototherapy

Indexed keywords

ALPHA2B INTERFERON; BCG VACCINE; BROPIRIMINE; CISPLATIN; DOXORUBICIN; METHOTREXATE; MITOMYCIN C; PHOTOFRIN; THIOTEPA; VINBLASTINE;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER IMMUNOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTECTOMY; DYSURIA; FEMALE; HEMATURIA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; INTRAVESICAL DRUG ADMINISTRATION; MALE; MULTICENTER STUDY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA; URINE INCONTINENCE;

EID: 0032324212     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)63021-0     Document Type: Article

References (23)

1. Lamm, D. L.: Carcinoma-in-situ. In: Superficial Bladder Cancer. Edited by F. Pagano and W. Fair. Oxford: Isis Medical Media Ltd., 1997.
2. Bergkvist, A., Ljungvist, A. and Moberger, G.: Classification of bladder tumours based on the cellular pattern. Preliminary report of a clinical-pathological study of 300 cases with a minimum follow-up of eight years. Acta. Chir. Scand., 130: 371, 1965.
3. Utz, D. C. and Farrow, G. M.: Management of carcinoma in situ of the bladder: the case for surgical management. Urol. Clin. N. Amer., 7: 533, 1980.
4. Hudson, M. A.: When intravesical measures fail. Indications for cystectomy in superficial disease. Urol. Clin. N. Amer., 19: 601, 1992.
5. Catalona, W. J., Hudson, M. A., Gillen, D. P., Andriole, G. L. and Ratliff, T. L.: Risks and benefits of repeated courses of intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer. J. Urol., 137: 220, 1987.
6. Nseyo, U. O.: Photodynamic therapy. Urol. Clin. N. Amer., 19: 591, 1992.
7. Walther, M. M., Delaney, T. F., Smith, P. D., Friauf, W. S., Thomas, G. F., Shawker, T. H., Vargas, M. P., Choyke, P. L., Linehan, W. M., Abraham, E. H., Okunieff, P. G. and Glatstein, E.: A phase I trial of photodynamic therapy in the treatment of recurrent superficial transitional cell carcinoma of the bladder. Urology, 50: 199, 1997.
8. Nseyo, U. O., Dougherty, T. J. and Sullivan, L.: Photodynamic therapy in the management of resistant lower urinary tract carcinoma. Cancer, 60: 3113, 1987.
9. Farrow, G. M., Utz, B. C. and Rife, C. C.: Morphological and clinical observations of patients with early bladder cancer treated with total cystectomy. Cancer Res., 36: 2495, 1976.
10. Benson, R. C., Jr.: Treatment of bladder cancer with hematoporphyrin derivatives and laser light. Urology, 23: 13, 1988.
11. Shumaker, B. P. and Hetzel, F. W.: Clinical laser photodynamic therapy in the treatment of bladder carcinoma. Photochem. Photobiol., 46: 899, 1987.
12. Prout, G. R., Jr., Lin, C. W., Benson, R., Jr., Nseyo, U. O., Daly, J. J., Griffin, P. P., Kinsey, J., Tian, M. E., Lao, Y. H. and Mian, Y. Z.: Photodynamic therapy with hematoporphyrin derivative in the treatment of superficial transitional-cell carcinoma of the bladder. New Engl. J. Med., 317: 1251, 1987.
13. Jocham, D., Beer, M., Baumgartner, R., Staehler, G. and Unsold, E.: Long-term experience with integral photodynamic therapy of TIS bladder carcinoma. Ciba Found. Symp., 146: 198, 1989.
14. D'Hallewin, M. A. and Baert, L.: Long-term results of whole bladder wall photodynamic therapy for carcinoma-in-situ of the bladder. Urology, 45: 763, 1995.
15. Manyak, M. J., Cole, J. W., McNellis, R. J. and Smith, P. D.: Downstaging of BCG-resistant carcinoma in situ of the bladder by photodynamic therapy with intravesical diffusion medium. J. Urol., part 2, 147: 374A, abstract 648, 1992.
16. Kreigmair, M., Waidelich, R., Lumper, W., Ehsan, A., Baumgartner, R. and Hofstetter, A.: Integral photodynamic therapy treatment of refractory superficial bladder cancer. J. Urol., 154: 1339, 1995.
17. Herr, H. W. and Whitmore, W. F., Jr.: Ureteral carcinoma in situ after successful intravesical therapy for superficial bladder tumors: incidence, possible pathogenesis and management. J. Urol., 138: 292, 1987.
18. Wood, D. P., Jr., Montie, J. E., Pontes, J. E. and Levin, H. S.: Identification of transitional cell carcinoma of the prostate in bladder cancer patients: a prospective study. J. Urol., 142: 83, 1989.
19. Henderson, B. W., Dougherty, T. J. and Malone, P. B.: Studies of tumor destruction by photo-radiation therapy. In: Porphyrin Localization and Treatment of Tumors. Edited by D. R. Doiron and C. J. Gomer. New York: Alan R. Liss, pp. 601-612, 1984.
20. Selman, S., Keck, R. and Kreimer-Birnbaum, M.: Acute blood flow changes in transplantable FANFT-induced urothelial tumors treated with hematoporphyrin derivatives and light. Surg. Forum, 34: 676, 1983.
21. Harty, J. I., Amin, M., Weiman, T. J., Tseng, M. T., Ackerman, D. and Broghamer, W.: Complications of whole bladder dihematoporphyrin ether photodynamic therapy. J. Urol., 141: 1341, 1989.
22. Nseyo, U. O., Kim, H. and DeBord, J.: Sequential whole bladder photodynamic therapy (WBPDT) treatments: a preclinical study. Urol. Oncol., 3: 27, 1997.
23. Potter, W. R., Mang, T. S. and Dougherty, T. J.: The theory of photodynamic therapy dosimetry: consequences of photodestruction of sensitizer. Photochem. Photobiol., 46: 97, 1987.